共同通信ニュース用語解説 「子宮頸がん」の解説
子宮頸がん
子宮
更新日:
出典 共同通信社 共同通信ニュース用語解説共同通信ニュース用語解説について 情報
子宮
更新日:
出典 共同通信社 共同通信ニュース用語解説共同通信ニュース用語解説について 情報
(1)de Sanjose S, Quint WG, Alemany L, et al; Retrospective International Survey and HPV Time Trends Study Group.Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.Lancet Oncol. 2010 ;11:1048-1056.
(2)国立がん研究センターがん情報サービス. 地域がん登録全国推計によるがん罹患データ(1975年~2011年). http://ganjoho.jp/reg_stat/statistics/dl/index.html アクセス日2015年5月1日
(3)国立がん研究センターがん情報サービス. 人口動態統計によるがん死亡データ(1958年~2013年). http://ganjoho.jp/reg_stat/statistics/dl/index.html アクセス日2015年5月1日
(4)Joura EA, Garland SM, Paavonen J, et al. FUTURE I and II Study Group; Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ. 2012 Mar 27;344:e1401.
(5)Dillner J, Kjaer SK, Wheeler CM, et al.FUTURE I/II Study Group;Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.BMJ. 2010 ;341:c3493.
(6)Rambout L, Hopkins L, Hutton B, et al.Prophylactic vaccination against human papillomavirus infection and disease inwomen: a systematic review of randomized controlled trials. CMAJ. 2007;177:469-479.
(7)Lu B, Kumar A, Castellsagué X, Giuliano AR. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis. 2011;11:13.
(8)Konno R, Tamura S, DobbelaereKetal.Efficacy of human papillomavirus type 16/18 AS04-adjuvanted vaccine in Japanese women aged 20 to 25 years: final analysis of a phase 2 double-blind, randomized controlled trial. Int J Gynecol Cancer. 2010 ;20:847-855.
(9)厚生労働省.子宮頸がん予防ワクチン(HPVワクチン)接種後の神経障害の診療について2015年4月1日. http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou28/dl/yobou150401-2.pdf アクセス日2015年5月4日
(10)Ronco G, Dillner J, Elfström KM, et al; International HPV screening working group.Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials.Lancet. 2014;383.524-532.
(11)Ronco G, Dillner J, Elfström KM, et al,eds. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National CancerInstitute. 2014.
(12)Smith RA, Manassaram-Baptiste D, Brooks D,et al.Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening.CA Cancer J Clin. 2015;65:30-54.
(13)Saslow D, Solomon D, Lawson HW, et al; American Cancer Society; American Society for Colposcopy and Cervical Pathology; American Society for Clinical Pathology.
(14)American Cancer Society. American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Am J ClinPathol. 2012 ;137:516-542.
(15)厚生労働省. 市町村のがん検診の項目について. http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000059490.html アクセス日2015年5月8日
(16)日本婦人科腫瘍学会.NCCNガイドライン 日本語版. 2014年版. http://www.tri-kobe.org/nccn/guideline/gynecological/ アクセス日2015年5月2日
(17)National Comprehensive Cancer Network ホームページ(NCCN:全米がんセンターガイドライン策定組織)NCCN Guidelines. Cervical Cancer 2015 ver.2. http://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf アクセス日2015年5月8日
(18)独立行政法人国立がん研究センターがん対策情報センター. 子宮と卵巣のがんの療養情報. http://ganjoho.jp/data/public/qa_links/brochure/odjrh3000000ul0q-att/141.pdf アクセス日2015年5月1日
(19)Eleje GU, Eke AC, Igberase GO, et al. Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.Cochrane Database Syst Rev. 2015 May 1;5:CD011000.
(20)Chi DS, Abu-Rustum NR, PlanteM et al. Cancer of cervix. In: TeLinde’s Operative Gynecology, 10th ed. Rock JA, Jones H. eds. Philadelphia Lippncott Williams and Wilikins:2008:1227.
(21)Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535-540.
(22)Lowrey GC, Mendenhall WM, Million RR.Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: a multivariate analysis. Int J RadiatOncol Biol Phys. 1992;24:205-210.
(23)Baalbergen A, Veenstra Y, StalpersL.Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev. 2013 Jan 31;1:CD006248.
(24)Galaal K, Al Moundhri M, Bryant A, et al.Adjuvant chemotherapy for advanced endometrial cancer.Cochrane Database Syst Rev. 2014 May 15;5:CD010681.
(25)Kokka F, Bryant A, Brockbank E, et al.Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.Cochrane Database Syst Rev. 2015 Apr 7;4:CD010260.
(26)Rosa DD, Medeiros LR, Edelweiss MI,et al. Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database Syst Rev. 2012 Jun 13;6:CD005342.
(27)Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration.:Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.J ClinOncol. 2008 ;26:5802:e5812.
(28)Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001;358:781-786.
(29)Rydzewska L, Tierney J, Vale CL, et al.Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007406.
(30)Katsumata N, Yoshikawa H, Kobayashi H; Japan Clinical Oncology Group. Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). Br J Cancer. 2013;108:1957-1963.
(31)Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.J Clin Oncol. 2000;18:1606-1613.
(32)Tewari KS, Sill MW, Long HJ, et al.Improved survival with bevacizumab in advanced cervical cancer.N Engl J Med. 2014;370:734-743.
出典 法研「EBM 正しい治療がわかる本」EBM 正しい治療がわかる本について 情報
10/29 小学館の図鑑NEO[新版]動物を追加
10/22 デジタル大辞泉を更新
10/22 デジタル大辞泉プラスを更新
10/1 共同通信ニュース用語解説を追加
9/20 日本大百科全書(ニッポニカ)を更新